Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

<div>Summary of the genes identified with SNVs in <i>IDH</i><sup><i>WT</i></sup> (<i>n</i> = 38) and <i>IDH</i><sup><i>MUT</i></sup> diffuse tumours (<i>n</i> = 3; cases 8a, 35a, and 39a). Genes are arranged hierarchically within their pathways for the RTK/Ras/PI(3)K (red), IDH (yellow), NOTCH, SHH, and WNT signalling (variations of green), p53 (blue), Rb (purple), and G-proteins (dark blue) pathways. Numbers across the top axis denote the patient identifier.</div>

Journal of Oncology

fig1

Figure 1

Figure 1: Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches 